Jennifer L. Fisher

Also affiliated with CFD Research Corporation (United States), University of Colorado Denver

Computer ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “CINmetrics: An R package for chromosomal instability analysis”.

CINmetrics: An R package for chromosomal instability analysis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.15.467294

N/A

0DataRank · unranked

1 citations

Jennifer L. Fisher, Roshan Darji, Brittany N. Lasseigne, Vishal H. Oza

Considerations and challenges for sex-aware drug repurposing

Biology of Sex Differences(2022)10.1186/s13293-022-00420-8

N/A

0DataRank · unranked

73 citations

Emma F. Jones, Victoria L. Flanary, Avery S. Williams, Elizabeth Wilk, Brittany N. Lasseigne +1 more

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.02.518863

N/A

0DataRank · unranked

0 citations

Timothy C. Howton, Jennifer L. Fisher, Vishal H. Oza, Ryan Brownlee, Kasi C. McPherson +6 more

CINmetrics: an R package for analyzing copy number aberrations as a measure of chromosomal instability

PeerJ(2023)10.7717/peerj.15244

N/A

0DataRank · unranked

15 citations

Jennifer L. Fisher, Roshan Darji, Brittany N. Lasseigne, Vishal H. Oza

Evaluating cancer cell line and patient‐derived xenograft recapitulation of tumor and non‐diseased tissue gene expression profiles in silico

Cancer Reports(2023)10.1002/cnr2.1874

N/A

0DataRank · unranked

8 citations

Elizabeth J. Wilk, Jennifer L. Fisher, Brittany N. Lasseigne, Avery S. Williams

Computational Advancements in Cancer Combination Therapy Prediction

JCO Precision Oncology(2023)10.1200/po.23.00261

N/A

0DataRank · unranked

7 citations

Jennifer L. Fisher, Elizabeth J. Wilk, Timothy C. Howton, Brittany N. Lasseigne, Victoria L. Flanary

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion

Molecular Medicine(2023)10.1186/s10020-023-00664-z

N/A

0DataRank · unranked

6 citations

Timothy C. Howton, Jennifer L. Fisher, Vishal H. Oza, Ryan Brownlee, Kasi C. McPherson +6 more

Sex-biased gene expression and gene-regulatory networks of sex-biased adverse event drug targets and drug metabolism genes

BMC Pharmacology and Toxicology(2024)10.1186/s40360-023-00727-1

N/A

0DataRank · unranked

7 citations

Amanda D. Clark, Emma F. Jones, Brittany N. Lasseigne, Jennifer L. Fisher

Signature reversion of three disease‐associated gene signatures prioritizes cancer drug repurposing candidates

FEBS Open Bio(2024)10.1002/2211-5463.13796

N/A

0DataRank · unranked

5 citations

Elizabeth J. Wilk, Vishal H. Oza, Sam E. Gary, Timothy C. Howton, Victoria L. Flanary +4 more